Skip to content

XOMA Corporation XOMA Royalty And Commercial Payment Receivables Cost Recovery Method Short Term

Royalty And Commercial Payment Receivables Cost Recovery Method Short Term at other companies

Theravance Biopharma logo
Theravance BiopharmaTBPH
$50M0.0%
Omeros logo
OmerosOMER
$25.48M-12.8%
Abercrombie & Fitch logo
Abercrombie & FitchANF
$34.31M+3.8%
Ceva logo
CevaCEVA
$9.16M+8.3%
NOVA, Inc. logo
NOVA, Inc.NOV
$43M+231%
NOVA, Inc. logo
NOVA, Inc.NOV
$137M+3.0%

Other financials

Income statement

See full
Revenue$12.3M-22.6%
Operating income-$480.0K-108%
Net income$4.5M+88.6%
EPS (diluted)$0.17+183%

Balance sheet

See full
Cash & equivalents$85.6M-5.2%
Total debt$124.7M+9.0%
Total equity$92.9M+9.7%
Total assets$271.9M+27.8%

Cash flow

See full
Operating cash flow$6.1M+178%
CapEx$3.0K-29.4%
Free cash flow-$2.9M+36.0%

Valuation

See full
Market cap$746.04M+159%
Enterprise value$785.17M+152%
P/E22.1×
P/S15.4×+8.7×

Profitability

See full
Operating margin10.2%+5.5pp
Net margin69.6%+64.0pp
FCF margin-320%-118pp

Returns & leverage

See full
Return on equity38.1%+35.2pp
Debt / equity1.3×0.0×
Current ratio3.6×-2.0×

Where this comes from

Reported directly by XOMA Corporation in its filing.

Tagged under the XBRL concept xoma:RoyaltyAndCommercialPaymentReceivablesCostRecoveryMethodShortTerm.

The official record: XOMA Corporation’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about XOMA Corporation's royalty and commercial payment receivables cost recovery method short term.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is XOMA Corporation's royalty and commercial payment receivables cost recovery method short term?
XOMA Corporation (XOMA) reported royalty and commercial payment receivables cost recovery method short term of $0 in Q1 2026.
How has XOMA Corporation's royalty and commercial payment receivables cost recovery method short term changed year-over-year?
XOMA Corporation's royalty and commercial payment receivables cost recovery method short term decreased by 100.0% year-over-year, from $413K to $0.
What is the long-term trend for XOMA Corporation's royalty and commercial payment receivables cost recovery method short term?
Over 2 years (2023 to 2025), XOMA Corporation's royalty and commercial payment receivables cost recovery method short term has grown at a -100.0% compound annual growth rate (CAGR), from $14.22M to $0.
What does royalty and commercial payment receivables cost recovery method short term mean?
This represents the short-term portion of royalty and commercial payment receivables accounted for under the cost recovery method. It indicates payments expected within one year where revenue recognition is deferred until the cost of the investment is recovered. This metric helps investors track the near-term cash inflows from assets that have not yet reached full profitability.